Elevated Circulating Pigment Epithelium-Derived Factor Predicts the Progression of Diabetic Nephropathy in Patients With Type 2 Diabetes

被引:51
|
作者
Hui, Elaine [1 ,2 ]
Yeung, Chun-Yip [1 ]
Lee, Paul C. H. [1 ]
Woo, Yu-Cho [1 ]
Fong, Carol H. Y. [1 ]
Chow, Wing-Sun [1 ]
Xu, Aimin [1 ,2 ,3 ]
Lam, Karen S. L. [1 ,2 ,3 ]
机构
[1] Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Res Ctr Heart Brain Hormones & Hlth Aging, Pokfulam, Hong Kong, Peoples R China
[3] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Pokfulam, Hong Kong, Peoples R China
来源
关键词
FACTOR PEDF; INSULIN-RESISTANCE; PLASMA-CONCENTRATION; METABOLIC SYNDROME; KIDNEY-FUNCTION; DISEASE; MARKER; LEVEL; ADIPOCYTES; CREATININE;
D O I
10.1210/jc.2014-2235
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Pigment epithelium-derived factor (PEDF), a circulating glycoprotein with antiangiogenic, antioxidative, and anti-inflammatory properties, protects against diabetic nephropathy (DN) in animal models. Objective: We investigated whether circulating PEDF predicted the progression of DN in a 4-year prospective study. Design, Setting, and Participants: Baseline plasma PEDF levels were measured in type 2 diabetic subjects recruited from the Hong Kong West Diabetes Registry. The role of PEDF in predicting chronic kidney disease (CKD) and albuminuria progression was analyzed using Cox regression analysis. Main Outcome Measure: We evaluated CKD progression, defined as deterioration in CKD staging and a 25% or greater drop in estimated glomerular filtration rate (eGFR) according to International Society of Nephrology statements. Results: At baseline, plasma PEDF levels increased progressively with CKD staging (P for trend <.001; n = 1136). Among 1071 subjects with baseline CKD stage <= 3, plasma PEDF levels were significantly higher in those with CKD progression(n = 171) during follow-up than those without(P < .001). Baseline PEDF was independently associated with CKD progression (hazard ratio = 2.76; 95% confidence interval = 1.39-5.47; P = .004), adjusted for age, sex, waist circumference, diabetes duration, hemoglobin A1c, systolic blood pressure, use of antihypertensive drugs, C-reactive protein, and eGFR. Elevated baseline PEDF was also associated with the development of microalbuminuria/albuminuria in a subgroup with normoalbuminuria and eGFR > 60 mL/min/1.73 m(2) (n = 462) at baseline (hazard ratio = 2.75; 95% confidence interval = 1.01-7.49; P < .05), even after adjustment for potential confounders. Conclusions: Elevated PEDF levels may represent a compensatory change in type 2 diabetic patients with renal disease and appear to be a useful marker for evaluating the progression of DN.
引用
收藏
页码:E2169 / E2177
页数:9
相关论文
共 50 条
  • [31] Involvement of matrix metal loproteinase-2 in down-regulation of pigment epithelium-derived factor in experimental diabetic nephropathy
    Fukami, K.
    Yamagishi, S. -I.
    Takamiya, Y.
    Ueda, S.
    Kaida, Y.
    Hayashida, A.
    Kusumoto, T.
    Koike, K.
    Okuda, S.
    DIABETOLOGIA, 2008, 51 : S480 - S481
  • [32] Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes
    Nakamura, Kazuo
    Yamagishi, Sho-ichi
    Adachi, Hisashi
    Kurita-Nakamura, Yayoi
    Matsui, Takanori
    Inoue, Hiroyoshi
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2009, 25 (01) : 52 - 56
  • [33] Pigment Epithelium-Derived Factor Expression in Colorectal Cancer Patients
    Wagsater, Dick
    Lofgren, Sture
    Zar, Niklas
    Hugander, Anders
    Dimberg, Jan
    CANCER INVESTIGATION, 2010, 28 (08) : 872 - 877
  • [34] Pigment epithelium-derived factor levels in the vitreous of patients with diabetic retinopathy and other retinal disorders
    Ogata, N
    Nishikawa, M
    Mitsuma, M
    Joyce, TT
    Nishimura, T
    Matsumura, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S206 - S206
  • [35] Relationship between pigment epithelium-derived factor (PEDF) and renal function in patients with diabetic retinopathy
    Matsuyama, Kayako
    Ogata, Nahoko
    Matsuoka, Masato
    Shima, Chieko
    Wada, Mitsumasa
    Jo, Nobuo
    Matsumura, Miyo
    MOLECULAR VISION, 2008, 14 (116-19): : 992 - 996
  • [36] Triglyceride-glucose index is prospectively associated with chronic kidney disease progression in Type 2 diabetes - mediation by pigment epithelium-derived factor
    Low, Serena
    Pek, Sharon
    Moh, Angela
    Ang, Keven
    Khoo, Jonathon
    Shao, Yi-Ming
    Tang, Wern E.
    Lim, Ziliang
    Subramaniam, Tavintharan
    Sum, Chee F.
    Lim, Su C.
    DIABETES & VASCULAR DISEASE RESEARCH, 2022, 19 (04):
  • [37] Pigment epithelium-derived factor Met72Thr polymorphism in patients with diabetic microangiopathy
    Yamagishi, S
    Amano, S
    Inagaki, Y
    Okamoto, T
    Koda, Y
    Soejima, M
    Kimura, H
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2002, 22 (3-4) : 67 - 71
  • [38] The role of pigment epithelium-derived factor in the progression of primary open angle glaucoma
    Blanch, Richard J.
    Hill, Lisa J.
    O'Neill, Jenna
    Murray, Philip Ian
    Masood, Imran
    Logan, Ann
    Ahmed, Zubair
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [39] Decreased pigment epithelium-derived factor expression in human breast cancer progression
    Cai, Jun
    Parr, Christian
    Watkins, Gareth
    Jiang, Wen G.
    Boulton, Mike
    CLINICAL CANCER RESEARCH, 2006, 12 (11) : 3510 - 3517
  • [40] Promoter polymorphisms of the pigment epithelium-derived factor gene are associated with diabetic retinopathy
    Iizuka, Hiroyuki
    Awata, Takuya
    Osaki, Masataka
    Neda, Tamotsu
    Kurihara, Susumu
    Inoue, Kiyoaki
    Inukai, Kouichi
    Kabasawa, Sho
    Mori, Keisuke
    Yoneya, Shin
    Katayama, Shigehiro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 361 (02) : 421 - 426